Delivery Order SPE2DB20D3101-SPE2DB24FRHE8
- Not listed
- This federal contract award is for the delivery of NovoLog 100 unit/mL FlexPen 3mL, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $2,275.80, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., on March 15, 2024. This is a delivery order contract with a firm fixed price, and the ultimate completion date is March 18, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- The U.S. Department of Defense's Defense Logistics Agency (DLA) has awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a $1,225.44 firm fixed price delivery order to provide NOVOLOG 100 UNIT/ML FLEXPEN 3ML pharmaceutical products. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, with a potential value of up to $999,999,999.00 and a performance period through December 31, 2025. The IDC serves...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The contract is for the delivery of NovoLog 100 Unit/mL Flexpen 3mL, a prescription medication, and has a ceiling value of $2,787.22. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, valued up to $999,999,999.00...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order valued at $3,741.72 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of 4,564,198,726 units of NOVOLOG 100 UNIT/ML FLEXPEN 3ML. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary...
- This federal contract award, valued at $4,715.00, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for 4,567,846,922 units of NOVOLOG 100 UNIT/ML FLEXPEN 3ML, a diabetes treatment medication. The contract is a firm fixed-price, non-set-aside award with an ultimate completion date of April 9, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,564,029,434 units of the NOVOLOG 100 UNIT/ML FLEXPEN 3ML pharmaceutical product. The contract has a ceiling value of $4,678.60 and a period of performance through March 21, 2024. No set-aside designation was used for this award. Amerisourcebergen Drug Corp also holds an indefinite delivery...
- This federal contract award, valued at $2,982.93, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of NovoLog 100 Unit/mL Flexpen 3mL, a prescription insulin product, with an ultimate completion date of April 29, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 2025. This...
- This federal contract award is for the delivery of NOVOLOG 100 UNIT/ML FLEXPEN 3ML pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency. The contract has a ceiling value of $4,002.84 and was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is February 19, 2025. The contract is not designated with a...
- This federal contract award, valued at $2,941.33, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of 4,567,926 units of NOVOLOG 100 UNIT/ML FLEXPEN 3ML, a diabetes medication. The contract has a firm fixed price and an ultimate completion date of April 16, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
- This federal contract award is for the delivery of Novolog 100 unit/mL Flexpen 3mL to the Defense Logistics Agency (DLA), a component of the Department of Defense (DoD). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $4,084.80 and is a firm fixed-price delivery order that runs through March 23, 2023. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB24FRHE8Delivery Order
This federal contract award is for the delivery of 4,564,361,766 units of NovoLog 100 Unit/mL Flexpen 3mL, a prescription medication, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, with a ceiling value of $3,025.76. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of April 23, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The company also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024. This contract award does not have a set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.0k | 4/22/24 |